These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24519928)

  • 1. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice.
    Tang SY; Monslow J; Todd L; Lawson J; Puré E; FitzGerald GA
    Circulation; 2014 Apr; 129(17):1761-9. PubMed ID: 24519928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deletions of cyclooxygenase-2 and atherogenesis in mice.
    Hui Y; Ricciotti E; Crichton I; Yu Z; Wang D; Stubbe J; Wang M; Puré E; FitzGerald GA
    Circulation; 2010 Jun; 121(24):2654-60. PubMed ID: 20530000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
    Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
    Praticò D; Tillmann C; Zhang ZB; Li H; FitzGerald GA
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3358-63. PubMed ID: 11248083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice.
    Choi JH; Jeon HJ; Park JG; Sonn SK; Lee MR; Lee MN; You HJ; Kim GY; Kim JH; Lee MH; Kwon OS; Nam KH; Kim HC; Jeong TS; Lee WS; Oh GT
    Atherosclerosis; 2010 Sep; 212(1):146-52. PubMed ID: 20684827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification.
    Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice.
    Yu Z; Crichton I; Tang SY; Hui Y; Ricciotti E; Levin MD; Lawson JA; Puré E; FitzGerald GA
    Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6727-32. PubMed ID: 22493243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice.
    Netherland CD; Pickle TG; Bales A; Thewke DP
    Atherosclerosis; 2010 Nov; 213(1):102-8. PubMed ID: 20846652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in
    Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice.
    Franco C; Hou G; Ahmad PJ; Fu EY; Koh L; Vogel WF; Bendeck MP
    Circ Res; 2008 May; 102(10):1202-11. PubMed ID: 18451340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
    Tang SY; Monslow J; R Grant G; Todd L; Pawelzik SC; Chen L; Lawson J; Puré E; FitzGerald GA
    Circulation; 2016 Jul; 134(4):328-38. PubMed ID: 27440004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.
    Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.
    Kitamoto S; Sukhova GK; Sun J; Yang M; Libby P; Love V; Duramad P; Sun C; Zhang Y; Yang X; Peters C; Shi GP
    Circulation; 2007 Apr; 115(15):2065-75. PubMed ID: 17404153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice.
    Burleigh ME; Babaev VR; Oates JA; Harris RC; Gautam S; Riendeau D; Marnett LJ; Morrow JD; Fazio S; Linton MF
    Circulation; 2002 Apr; 105(15):1816-23. PubMed ID: 11956125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells.
    Fredenburgh LE; Liang OD; Macias AA; Polte TR; Liu X; Riascos DF; Chung SW; Schissel SL; Ingber DE; Mitsialis SA; Kourembanas S; Perrella MA
    Circulation; 2008 Apr; 117(16):2114-22. PubMed ID: 18391113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.
    Egan KM; Wang M; Fries S; Lucitt MB; Zukas AM; Puré E; Lawson JA; FitzGerald GA
    Circulation; 2005 Jan; 111(3):334-42. PubMed ID: 15655126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Superoxide Dismutase 2 Activity Induces Atherosclerotic Plaque Instability During Aging in Hyperlipidemic Mice.
    Vendrov AE; Stevenson MD; Alahari S; Pan H; Wickline SA; Madamanchi NR; Runge MS
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions.
    Ylä-Herttuala S; Lipton BA; Rosenfeld ME; Goldberg IJ; Steinberg D; Witztum JL
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10143-7. PubMed ID: 1719546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
    She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.